ACET Quote, Trading Chart, Aceto Corporation

$ Last:

Change Percent:

$ Open:

$ Previous Close:

$ High:

$ Low:

0 Volume:

01/01/1970 12:00:00 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2021-03-04	15.44	13.79	15.68	13.63	202,670
2021-03-03	15.57	15.59	16	14.81	197,379
2021-03-02	15.47	15.75	15.79	15.12	165,711
2021-03-01	15.405	15.6	15.88	14.62	121,230
2021-02-26	15.85	15.31	15.85	14.77	218,337
2021-02-25	16.34	15.75	16.89	15.4701	89,451
2021-02-24	15.72	16.4	16.89	15.56	86,169
2021-02-23	15.99	15.71	15.99	14.27	228,684
2021-02-22	16.17	16.28	17.12	15.855	153,007
2021-02-19	16.05	16.12	16.38	15.3	93,452
2021-02-18	16	15.8	16.5	14.01	420,050
2021-02-17	16.75	16.11	16.82	15.53	316,080
2021-02-16	16.82	16.75	17.17	16.27	272,505
2021-02-15	17.26	16.82	17.26	15.35	192,003
2021-02-12	17.26	16.82	17.26	15.35	192,003
2021-02-11	16.17	17.17	17.545	15.05	288,213
2021-02-10	14.5	16.7	17.8	14.09	1,565,139
2021-02-09	14.12	13.69	14.16	13.4771	36,853
2021-02-08	12.67	13.97	14.08	12.67	97,471
2021-02-05	12.61	12.67	13.23	12.13	95,201

Stock Information

Aceto Corporation Company Name:

ACET Stock Symbol:

NASDAQ Market:

Aceto Corporation Website:

Get ACET Alerts

News, Short Squeeze, Breakout and More Instantly...

ACET - Adicet Bio Appoints Dr. Andrew Sinclair to its Board of Directors

MENLO PARK, Calif. and BOSTON, March 04, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the appointment of Andrew Sinclair, Ph.D., to its boar...
ACET - Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

MENLO PARK, Calif. and BOSTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the closing of an under...
ACET - Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

MENLO PARK, Calif. and BOSTON, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the pricing of an underwritten...